Collegium Pharmaceutical
COLL
COLL
163 hedge funds and large institutions have $900M invested in Collegium Pharmaceutical in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 50 increasing their positions, 54 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
18% more funds holding
Funds holding: 138 → 163 (+25)
1.85% more ownership
Funds ownership: 107.49% → 109.35% (+1.9%)
7% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 54
Holders
163
Holding in Top 10
2
Calls
$2.42M
Puts
$1.43M
Top Buyers
| 1 | +$72.2M | |
| 2 | +$11.7M | |
| 3 | +$10.8M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$10.4M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
+$7.91M |
Top Sellers
| 1 | -$25.6M | |
| 2 | -$25.1M | |
| 3 | -$24M | |
| 4 |
FM
Frazier Management
Seattle,
Washington
|
-$18.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$11.8M |